Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Fountainview offers innovative amenities for independent seniors

Fountainview at Eisenberg Village, a Continuing Care Retirement Community (CCRC), will officially open its doors for Charter Members to begin moving in on Monday, February 15, 2010.

7 Jan 2010

Diffusion tensor imaging detects signs of Alzheimer's disease

A new type of brain scan, called diffusion tensor imaging (DTI), appears to be better at detecting whether a person with memory loss might have brain changes of Alzheimer's disease, according to a new study published in the January 6, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

7 Jan 2010

New evidence suggests long-term exposure to cell phone signals may protect against Alzheimer's disease

The millions of people who spend hours every day on a cell phone may have a new excuse for yakking. A surprising new study in mice provides the first evidence that long-term exposure to electromagnetic waves associated with cell phone use may actually protect against, and even reverse, Alzheimer's disease.

6 Jan 2010

University of Montreal expands treatment capacity with EON Reality's simulations system

EON Reality, the world's leading interactive 3D software provider, today announced that the Visual Psychophysics and Perception Laboratory at the University of Montreal expands their treatment capacity with a fully immersive environment from EON Reality. A new simulations system for rehabilitation and training of athletic performance, developed by Professor Jocelyn Faubert's team, will be immersed within the EON Icube, a technology that allows virtual training in a natural and realistic environment.

6 Jan 2010

SAVE THE PATIENT to host community show to help seniors navigate long-term care issues

Senior citizens and their families often feel overwhelmed when dealing with health issues. Finding the right care services to fit their needs can be a daunting task -- but need not be. SAVE THE PATIENT is hosting another community show to bring insights, ideas and understandable answers to the Chicago public.

6 Jan 2010

EnVivo Pharmaceuticals announces initiation and dosing of patients in Phase 2b study of EVP-6124

EnVivo Pharmaceuticals today announced the initiation and dosing of patients in a Phase 2b study of its EVP-6124 compound, a selective alpha-7 nicotinic agonist in patients with schizophrenia. EnVivo is conducting the multi-center, dose ranging, placebo controlled, three-month study in the U.S. and Europe.

6 Jan 2010

Study identifies novel factor that causes Alzheimer's disease

Inheritance of an extra copy of the gene- β -amyloid precursor protein, APP, in individuals with Down syndrome leads to the inevitable development of early onset Alzheimer's disease, known to be linked to the deposition of Amyloid β peptide or Aβ in the brain.

5 Jan 2010

FDA approves generic donepezil hydrochloride orally disintegrating tablets

The U.S. Food and Drug Administration approved the first generic versions of Aricept (donepezil hydrochloride) orally disintegrating tablets on Dec. 11. Donepezil hydrochloride is indicated for the treatment of dementia related to Alzheimer's disease.

5 Jan 2010

Rising prevalence of dementia will cripple Canadian families, the health care system and economy

A report released by the Alzheimer Society today to mark Alzheimer Awareness Month reveals alarming new statistics about the projected economic and social costs of dementia in Canada. Rising Tide: The Impact of Dementia on Canadian Society, says that, if nothing changes the prevalence of dementia will more than double in 30 years, with the costs increasing ten-fold.

4 Jan 2010

Aegis Living provides guidance on senior living communities

It's a fact: each and every January senior living communities see an increase in inquiries from concerned family members looking for help and answers as to how to best care for an aging loved one that needs assistance

4 Jan 2010

D-Pharm commences enrollment in MACSI Phase III clinical study for acute ischemic stroke

D-Pharm Ltd announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).

3 Jan 2010

TENS therapy is not effective against chronic low-back pain

A new guideline issued by the American Academy of Neurology finds that transcutaneous electric nerve stimulation (TENS), a widely used pain therapy involving a portable device, is not recommended to treat chronic low-back pain that has persisted for three months or longer because research shows it is not effective.

31 Dec 2009

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

Cryo-Cell International, Inc. a global leader in stem cell innovation, resolves to help women inspire and empower each other to take charge of their health in the New Year, and to spark conversations about the promise of stem cells.

31 Dec 2009

Book underlines the importance of positive emotions, spirituality and wisdom for successful aging

It's never too early or too late to start working toward the goal of improving brain health. So perhaps the New Year is the perfect time to consider how one achieves a long and satisfying life. A book recently publishing by American Psychiatric Publishing, Inc., called Successful Cognitive and Emotional Aging may be just the tool to help find some answers to the age-old question.

30 Dec 2009

Service dogs for people with disabilities

When disability or illness makes it difficult to open a door, pick up keys or call for help, a service dog might ease these frustrations of daily living.

30 Dec 2009

Significant limitations in new Ginkgo biloba study published in JAMA, says ABC

New research findings published this week on a standardized Ginkgo biloba extract are very limited and the public should focus on the well-documented cognitive and cardiovascular benefits of ginkgo, said the American Botanical Council (ABC), an independent nonprofit research and education organization.

30 Dec 2009

CRN stands by Ginkgo biloba's effectiveness in improving cognitive function

"It is important to put this study into context and to remember that there is a large body of previously published evidence, which suggests that Ginkgo biloba may help improve cognitive impairment in older adults. There are also additional ongoing clinical trials, the results of which may address some of the limitations of the current study. The results of this single study add to the overall data on Ginkgo biloba, including valuable evidence in support of Ginkgo's safety profile, but should not be viewed as the final word.

30 Dec 2009

Ginkgo biloba does not slow rate of cognitive decline in older adults

Older adults who used the herbal supplement Ginkgo biloba for several years did not have a slower rate of cognitive decline compared to adults who received placebo, according to a study in the December 23/30 issue of JAMA.

30 Dec 2009

Emerald BioStructures engineers new allosteric small molecule modulators of the PDE4 enzyme

Emerald BioStructures (formerly deCODE biostructures) announced today a publication in the December 27, 2009 advance online issue of Nature Biotechnology, detailing the application of structure-based drug design (SBDD) to engineer new allosteric small molecule modulators of the enzyme phosphodiesterase-4 (PDE4), with reduced side effects. According to the paper, the researchers established the structural basis of PDE4 regulation through crystal structures of the PDE4 regulatory domain in contact with small molecules.

29 Dec 2009

New evidence suggests amyloid beta plays a critical role in synaptic failure

The early stages of Alzheimer's disease are thought to occur at the synapse, since synapse loss is associated with memory dysfunction. Evidence suggests that amyloid beta (Aβ) plays an important role in early synaptic failure, but little has been understood about Aβ's effect on the plasticity of dendritic spines.

29 Dec 2009

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Fountainview offers innovative amenities for independent seniors

Diffusion tensor imaging detects signs of Alzheimer's disease

New evidence suggests long-term exposure to cell phone signals may protect against Alzheimer's disease

University of Montreal expands treatment capacity with EON Reality's simulations system

SAVE THE PATIENT to host community show to help seniors navigate long-term care issues

EnVivo Pharmaceuticals announces initiation and dosing of patients in Phase 2b study of EVP-6124

Study identifies novel factor that causes Alzheimer's disease

FDA approves generic donepezil hydrochloride orally disintegrating tablets

Rising prevalence of dementia will cripple Canadian families, the health care system and economy

Aegis Living provides guidance on senior living communities

D-Pharm commences enrollment in MACSI Phase III clinical study for acute ischemic stroke

TENS therapy is not effective against chronic low-back pain

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

Book underlines the importance of positive emotions, spirituality and wisdom for successful aging

Service dogs for people with disabilities

Significant limitations in new Ginkgo biloba study published in JAMA, says ABC

CRN stands by Ginkgo biloba's effectiveness in improving cognitive function

Ginkgo biloba does not slow rate of cognitive decline in older adults

Emerald BioStructures engineers new allosteric small molecule modulators of the PDE4 enzyme

New evidence suggests amyloid beta plays a critical role in synaptic failure

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in